Abstract
Background/Aims: The roles of inflammatory and fibrogenic biomarkers in chronic hepatitis B (CHB) infection and hepatitis B virüs (HBV)-related cirrhosis remain incompletely understood. The current study investigated the diagnostic and discriminative ability of amphiregulin (AREG), interleukin-6 (IL-6), and neuropilin-1 (Nrp-1) as biomarkers of HBV-related cirrhosis.
Materials and Methods: This cross-sectional analytical study included 70 patients with CHB (43 without cirrhosis and 27 with HBVrelated cirrhosis) and 60 healthy controls. Clinical and laboratory data were obtained from hospital records. Serum IL-6, Nrp-1, and AREG levels collected during outpatient visits were measured using enzyme-linked immunosorbent assay. Group differences were analyzed using the Kruskal–Wallis test, discriminative performance was evaluated using receiver operating characteristic (ROC) analysis, and factors independently associated with cirrhosis were identified using logistic regression.
Results: IL-6 and Nrp-1 levels were higher in patients with noncirrhotic and HBV-related cirrhotic CHB than in healthy controls (P < .001), with no significant difference between the patient subgroups. AREG levels were lower in the overall CHB cohort than in controls (P < .001) but higher in patients with cirrhosis than in those without cirrhosis (P = .001). ROC analysis showed that AREG had moderate discriminative ability for HBV-related cirrhosis (area under the curve (AUC) = 0.749). The optimal Youden-derived cutoff value was 2.29 ng/mL, with a sensitivity of 74% and a specificity of 65%. In logistic regression, AREG was independently associated with HBV-related cirrhosis (P = .012). Addition of ln-transformed AREG to age- and sex-adjusted aspartate aminotransferase-to-platelet ratio index (APRI)- and Fibrosis-4 index (FIB-4)-based models increased the AUC from 0.923 to 0.970 and from 0.938 to 0.980, respectively.
Conclusion: AREG may serve as a complementary biomarker with moderate discriminative value for HBV-related cirrhosis but is unlikely to be useful as a standalone diagnostic or prognostic marker. Although IL-6 and Nrp-1 reflected underlying inflammatory activity, their ability to distinguish cirrhosis was limited.
Cite this article as: Karakoc Ozudogru F, Karaca B, Turker N, et al. Discriminative role of interleukin-6, neuropilin-1, and amphiregulin for cirrhosis in patients with chronic hepatitis B infection. Turk J Gastroenterol. 2026;37(9):985-994.
Most read articles by the same author(s)
- Ahmet AYDIN, Fatih TEKİN, Fulya GÜNŞAR, Adem GÜLER, Müge TUNÇYÜREK, Tankut İLTER, Value of endoscopic ultrasonography for upper gastrointestinal stromal tumors: A single center experience , Turkish Journal of Gastroenterology: Vol. 15 No. 4 (2004): Turkish Journal of Gastroenterology
- Galip ERSÖZ, Ulus Salih AKARCA, Fulya GÜNŞAR, Zeki KARASU, Yücel BATUR, Interferon re-treatment for resistance to lamivudine plus interferon treatment , Turkish Journal of Gastroenterology: Vol. 14 No. 4 (2003): Turkish Journal of Gastroenterology
- Neşe Demirtürk, Bilgehan Aygen, İlhami Çelik, Reşit Mıstık, Sıla Akhan, Şener Barut, Onur Ural, Ayşe Batırel, Funda Şimşek, Gülden Ersöz, Dilara İnan, Sami Kınıklı, Nesrin Türker, Hüseyin Bilgin, Yunus Gürbüz, Necla Tülek, Hüseyin Tarakçı, Orhan Yıldız, Emine Türkoğlu, Deniz Kamalak Güzel, Sümeyra Şimşek, Nazan Tuna, Nazlım Aktuğ Demir, Atahan Çağatay, Rıza Aytaç Çetinkaya, Faruk Karakeçili, İsmail Necati Hakyemez, Günay Tuncer Ertem, Bahar Örmen, Pınar Korkmaz, Uluhan Yıldız, Ziya Kuruüzüm, Alper Şener, Selcan Arslan Özel, Sinan Öztürk, Kaya Suer, Mustafa Kemal Çelen, Petek Konya, Ali Asan, Neşe Saltoğlu, Nurhan Doğan, Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective? , Turkish Journal of Gastroenterology: Vol. 32 No. 2 (2021): Turkish Journal of Gastroenterology
- Mahmut Arabul, Fatih Aslan, Emrah Alper, Zehra Akpınar, Mustafa Çelik, Altay KANDEMİR, Sezgin VATANSEVER, Belkıs Ünsal, Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients , Turkish Journal of Gastroenterology: Vol. 23 No. 5 (2012): Turkish Journal of Gastroenterology
- Emrah Alper, Behlül BAYDAR, Sezgin VATANSEVER, Zafer BUYRAÇ, Fatih Aslan, Zehra Akpınar, M.Kadir AKSÖZ, Serdar AKÇA, Belkıs Ünsal, Does presence of common bile duct stones in patients with acute biliary pancreatitis affect the severity of illness or laboratory findings? , Turkish Journal of Gastroenterology: Vol. 22 No. 5 (2011): Turkish Journal of Gastroenterology
- Fatih TEKİN, Sezgin VATANSEVER, Ömer ÖZÜTEMİZ, Ahmet MUSOĞLU, Tankut İLTER, Severe exudative ascites as an initial presentation of Crohn’s disease , Turkish Journal of Gastroenterology: Vol. 16 No. 3 (2005): Turkish Journal of Gastroenterology
- Murat AKYILDIZ, Fulya GÜNŞAR, Sinan AKAY, Başak DOĞANAVŞARGİL, Ömer ÖZÜTEMİZ, Liver penetration of duodenal ulcer , Turkish Journal of Gastroenterology: Vol. 17 No. 4 (2006): Turkish Journal of Gastroenterology
- Sezgin Vatansever, Zehra Akpınar, Emrah Alper, Serkan İpek, Nafi Yazıcıoğlu, Neşe Ekinci, Belkıs Ünsal, Gastric polyps and polypoid lesions: Retrospective analysis of 36650 endoscopic procedures in 29940 patients , Turkish Journal of Gastroenterology: Vol. 26 No. 2 (2015): Turkish Journal of Gastroenterology
- Nilay Danış, Fulya Günşar, Liver Transplantation for Autoimmune Hepatitis: Infections are the Major Cause of Mortality , Turkish Journal of Gastroenterology: Vol. 36 No. 3 (2025): Turkish Journal of Gastroenterology
- Fulya GÜNŞAR, Yaman TOKAT, Zeki KARASU, Ulus Salih AKARCA, Tijen ÖZACAR, Gül YÜCE, Combination therapy with lamivudine and low dosehepatitis-B immune globulin against hepatitis-B recurrence after liver transplantation , Turkish Journal of Gastroenterology: Vol. 11 No. 3 (2000): Turkish Journal of Gastroenterology

This work is licensed under a Creative Commons Attribution 4.0 International License.